Author

Christopher Divsalar

Institution: Fresenius Kabi (United States)

Observed institution: Fresenius Kabi (United States)

ORCID: 0009-0001-9019-2602

Observed ORCID: 0009-0001-9019-2602

OpenAlex ID: A5028917405

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy

2023 · Romina Marone, Emmanuelle Landmann, et al. · The Journal of Experimental Medicine · 40

Prime Editing Enables Precise and Efficient Single Amino Acid Substitutions to Shield CD34+ Hematopoietic Stem Cells from Anti-CD117 Antibody-Based Conditioning

2024 · Jack M Heath, Justin G Tedeschi, et al. · Blood · 3

Function-Preserving Single Amino Acid Substitutions Shield Hematopoietic Stem and Progenitor Cells from CD117 Targeted Immunotherapy In Vivo

2022 · Romina Marone, Rosalba Lepore, et al. · Blood · 3

CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates a β-thalassemia model

2026 · Romina Marone, Rosalba Lepore, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Engineered Single Amino Acid Substitutions Protect Hematopoietic Stem and Progenitor Cells from CD123 Targeted Immunotherapy

2022 · Emmanuelle Landmann, Anna Devaux, et al. · Blood

Works count: 5

Citation count: 46

H-index: 3

I10-index: 1